Excerpt from Ru-486, Status Report on the U. S. Commercialization Project, Transfer of Antiprogestin Technology to the United States: Hearing Before the Subcommittee on Regulation, Business Opportunities, and Technology of the Committee on Small Business, House of Representatives, One Hundred Third Congress, Second Session; May 16, 1994 Chairman wyden. Welcome, Congresswoman Schroeder. We know that you have been mobilizing support for these kinds of women's health issues for many, many years and have done much to make this day possible. We, will make any prepared remarks you would like a part of the record. Please proceed as you wish